European cancer deaths rising slower than diagnoses

16 January 2020
cancerbig

A higher number of people are currently being diagnosed with cancer in Europe than at any point since 1995, yet fewer of these people are dying of the disease, according to a new study.

The Comparator Report on Cancer in Europe 2020 found that the absolute number of people diagnosed with cancer rose around 50% in the continent over the past 20 years, where deaths only increased by 20%.

In fact, allowing for population growth and aging, in real terms cancer deaths are actually falling.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical